BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

290 hedge funds and large institutions have $1.76B invested in BioCryst Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 111 increasing their positions, 84 reducing their positions, and 29 closing their positions.

Holders
290
Holders Change
+18
Holders Change %
+6.62%
% of All Funds
3.89%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
51
Increased
111
Reduced
84
Closed
29
Calls
$12.2M
Puts
$5.49M
Net Calls
+$6.74M
Net Calls Change
+$1.96M

Top Buyers

1
Arrowstreet Capital
1
Arrowstreet Capital
Massachusetts
$38.3M
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$32.4M
3
UBS Group
3
UBS Group
Switzerland
$50.3M
4
Morgan Stanley
4
Morgan Stanley
New York
$47.8M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$39.3M

Top Sellers

1
ACA
1
Avoro Capital Advisors
New York
$40.3M
2
RM
2
RP Management
New York
$0
3
CP
3
Caligan Partners
New York
$5.72M
4
Millennium Management
4
Millennium Management
New York
$17.1M
5
Ameriprise
5
Ameriprise
Minnesota
$960K
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$192M 21,425,849 -1,343,397 -6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$184M 20,544,248 -1,115,517 -5%
State Street
3
State Street
Massachusetts
$76.2M 8,505,392 +691,988 +9%
KCM
4
Kynam Capital Management
New Jersey
$75.8M 8,463,742 -464,781 -5%
Alkeon Capital Management
5
Alkeon Capital Management
New York
$51.2M 5,714,021 -1,500,000 -21%
UBS Group
6
UBS Group
Switzerland
$50.3M 5,614,651 +3,211,465 +134%
Morgan Stanley
7
Morgan Stanley
New York
$47.8M 5,329,679 +3,032,005 +132%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$45.3M 5,054,610 +93,973 +2%
DM
9
Deerfield Management
New York
$42M 4,692,000 -497,665 -10%
ACA
10
Avoro Capital Advisors
New York
$40.3M 4,500,000 -4,200,000 -48%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$39.3M 4,389,477 +2,800,365 +176%
Two Sigma Investments
12
Two Sigma Investments
New York
$38.4M 4,288,223 +2,242,688 +110%
Arrowstreet Capital
13
Arrowstreet Capital
Massachusetts
$38.3M 4,278,555 +4,084,403 +2,104%
Two Sigma Advisers
14
Two Sigma Advisers
New York
$37.9M 4,228,412 +1,007,700 +31%
Assenagon Asset Management
15
Assenagon Asset Management
Luxembourg
$32.4M 3,620,637 +3,606,566 +25,631%
NL
16
Nuveen LLC
North Carolina
$31.7M 3,534,454 +2,110,808 +148%
Goldman Sachs
17
Goldman Sachs
New York
$31.6M 3,523,917 +1,591,983 +82%
Bank of America
18
Bank of America
North Carolina
$25.5M 2,841,155 +1,405,498 +98%
Fisher Asset Management
19
Fisher Asset Management
Washington
$24.9M 2,782,489 -269,648 -9%
GKIM
20
GW&K Investment Management
Massachusetts
$23.5M 2,623,537 -261,143 -9%
Citadel Advisors
21
Citadel Advisors
Florida
$22.9M 2,557,432 +1,983,243 +345%
Renaissance Technologies
22
Renaissance Technologies
New York
$22.6M 2,526,734 +1,921,516 +317%
Voloridge Investment Management
23
Voloridge Investment Management
Florida
$22.2M 2,474,075 +440,292 +22%
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$21.3M 2,373,489 +1,432,824 +152%
Walleye Capital
25
Walleye Capital
New York
$20.6M 2,300,628 +2,145,936 +1,387%
1
2 3 4 5